HMCNX
Price
$15.09
Change
-$0.08 (-0.53%)
Updated
Aug 15 closing price
Net Assets
170.32M
VIMSX
Price
$78.00
Change
-$0.19 (-0.24%)
Updated
Aug 15 closing price
Net Assets
196.76B
Interact to see
Advertisement

HMCNX vs VIMSX

Header iconHMCNX vs VIMSX Comparison
Open Charts HMCNX vs VIMSXBanner chart's image
Harbor Mid Cap Investor
Price$15.09
Change-$0.08 (-0.53%)
VolumeN/A
Net Assets170.32M
Vanguard Mid Cap Index Investor
Price$78.00
Change-$0.19 (-0.24%)
VolumeN/A
Net Assets196.76B
HMCNX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HMCNX vs. VIMSX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMCNX is a StrongBuy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 197B vs. HMCNX (170M). VIMSX pays higher dividends than HMCNX: VIMSX (1.37) vs HMCNX (0.00). HMCNX was incepted earlier than VIMSX: HMCNX (6 years) vs VIMSX (27 years). HMCNX (1.29) is less costly to investors than VIMSX (0.17). HMCNX is a more actively managed with annual turnover of: 18.00 vs. VIMSX (16.00). HMCNX has a lower initial minimum investment than VIMSX: HMCNX (2500) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 14.59 vs. HMCNX (4.62). VIMSX return over 5 years is better than : 62.56 vs. HMCNX (44.56).
HMCNXVIMSXHMCNX / VIMSX
Total Expense Ratio1.230.17724%
Annual Report Gross Expense Ratio1.290.17759%
Fund Existence6 years27 years-
Gain YTD3.9048.55546%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets170M197B0%
Annual Yield % from dividends0.001.37-
Returns for 1 year4.6214.5932%
Returns for 3 years9.0726.7034%
Returns for 5 years44.5662.5671%
Returns for 10 yearsN/A125.64-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROKU90.292.78
+3.18%
Roku
NNNN50.910.77
+1.54%
Anbio Biotechnology
ABOS1.420.02
+1.43%
Acumen Pharmaceuticals
KIDS19.190.06
+0.31%
OrthoPediatrics Corp
ASNS0.51-0.11
-17.94%
Actelis Networks